Detection of Chromosome Aberrations in the Second Trimester Using Genetic Amniocentesis: Experience During 1995-2004

Article Outline

• Summary
• References
• Copyright

Summary 

Objective

To retrospectively investigate the 10-year experience of prenatal diagnosis of fetal chromosome aberrations by second-trimester amniocentesis.

Methods

Data were collected at Taichung Veterans General Hospital between 1995 and 2004 from cytogenetic analyses of cultured amniocytes from second-trimester amniocentesis. The main indications for amniocentesis included advanced maternal age, abnormal maternal serum screening results, and abnormal ultrasound findings. Chromosome aberrations included autosomal aneuploidies, sex chromosome aneuploidies, polyploidies, and rearrangements. Variant chromosomes were considered to be normal and excluded.

Results

A total of 7,028 amniocenteses were performed and analyzed for chromosome aberrations. Among these, 4,026 (57.29%) were for advanced maternal age, 1,500 (21.34%) for abnormal maternal serum screening results, 553 (7.87%) for abnormal ultrasound findings, and 949 (13.50%) for other reasons. The highest detection rate of chromosome aberrations was in cases undergoing amniocentesis for abnormal ultrasound findings (8.86%), followed by other reasons (2.74%), abnormal maternal serum screening results (2.60%), and advanced maternal age (2.31%). Chromosome aberrations were detected in 207 cases (2.90%), including fetuses of 93 older mothers, 39 mothers with abnormal serum screening results, 49 mothers with abnormal ultrasound findings, and 26 mothers with other reasons for amniocentesis. Of fetuses with chromosome aberrations, 144 (69.56%) had trisomy 13, trisomy 18, trisomy 21, or sex chromosome disorder. The other 63 cases (30.44%) included balanced translocation, unbalanced abnormality, inversion, and marker chromosome.

Conclusion

For daily practice, our data could offer a database for proper genetic counseling, such as termination issues and future pregnancies.

Key Words:  amniocentesis , chromosome aberration

No full text is available. To read the body of this article, please view the PDF online.

Back to Article Outline

References 

1. Platt LD , DeVore GR , Lopez E , Herbert W , Falk R , Alfi O . Role of amniocentesis in ultrasound-detected fetal malformations . Obstet Gynecol . 1986;68:153–155
   • View In Article
   • MEDLINE
2. Rochelson BL , Trunca C , Monheit AG , Baker DA . The use of a rapid in situ technique for third-trimester diagnosis of trisomy 18 . Am J Obstet Gynecol . 1986;155:835–836
   • View In Article
   • MEDLINE
3. Hook EB . Down's syndrome epidemiology and biochemical screening . In:  Grudzinskas JG ,  Chard T ,  Chapman M ,  Cuckle H editor. Screening for Down's Syndrome . Cambridge: Cambridge University Press; 1994;p. 1–18
   • View In Article
4. Chen CP , Lin CJ , Wang W . Impact of second-trimester maternal serum screening on prenatal diagnosis of Down's syndrome and the use of amniocentesis in the Taiwanese population. The Taiwan Amniocentesis Collaborative Study Group . Taiwanese J Obstet Gynecol . 2005;44:31–35
   • View In Article
5. Benn PA , Egan JFX , Fang M , Smith-Bindman R . Changes in the utilization of prenatal diagnosis . Obstet Gynecol . 2004;103:1255–1260
   • View In Article
   • MEDLINE
   • CrossRef